Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05802914 · ClinicalTrials.gov registry record · NA

Soft Active Back Exosuit to Reduce Workplace Back Pain

A NA study of Low Back Pain and Musculoskeletal Pain, sponsored by Wyss Institute at Harvard University.

Completed
Registry status
NA
Development phase
97
Enrollment target
1
Study location

NCT05802914: Completed NA study of Low Back Pain and Musculoskeletal Pain, sponsored by Wyss Institute at Harvard University.

NCT05802914 is a NA study of Low Back Pain and Musculoskeletal Pain that has completed, run by Wyss Institute at Harvard University. The registered enrollment target is 97 participants, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05802914, a NA study of Low Back Pain and Musculoskeletal Pain, has completed, sponsored by Wyss Institute at Harvard University.

COMPLETED
Registry status
NA
Development phase
97 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to determine if a wearable back exosuit can make it safer and easier for workers who bend, lift, and lower objects in an industrial setting. Many studies have shown that wearable back exoskeletons or exosuits can provide helpful forces making a person's back muscles work less. It is believed that exosuits can lower a person's level of workplace effort and fatigue, making it less likely for them to have back pain at work. Back exosuits could be a solution to make a job easier, but how well they work in the real-world over a long period of time is unclear. The investigators want to know if workers who wear a back exosuit during the workday will have lower rates of lower back pain or injury than those who are not wearing a back exosuit. The investigators also want to know how well exosuit technology integrates into the workplace (for example, how this technology improves or hinders job performance). Participants will be randomized into an exosuit group or control group. Participants in the exosuit group will be given a back exosuit that they can use as much as they want at work. All participants will complete surveys monthly. Researchers will compare the exosuit group to the control group to see if using a back exosuit in a workplace can reduce a person's risk and impact of low back injury or pain. The investigators also want to see if a back exosuit impacts job productivity and if participants find the exosuit becomes useful or bothersome over time.

Primary Outcome

The Cornell Musculoskeletal Discomfort Questionnaire (MDQ) is a composite score that considers the frequency, severity, and work interference of body aches and pains. The back pain score will be evaluated between the 2 groups at 5 time points.

Interventions

  • DEVICE Back Exosuit

Study Locations (1)

Kentucky

  • Undisclosed Location - Louisville

Trial Details

FieldValue
Enrollment Target 97 participants
Start Date 2023-02-08
Est. Completion 2025-04-26
Phase NA

What the finished NCT05802914 record still lists

NCT05802914 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 97 participants, a relatively small participant target, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (81% lower).

The record links to 3 conditions, with Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Back Exosuit is the first listed.

NCT05802914 reports a single indexed study location in Kentucky.

Frequently Asked Questions

What is clinical trial NCT05802914 about?

NCT05802914 is a clinical study titled "Soft Active Back Exosuit to Reduce Workplace Back Pain". The goal of this clinical trial is to determine if a wearable back exosuit can make it safer and easier for workers who bend, lift, and lower objects in an industrial setting. Many studies have shown that wearable back exoskeletons or exosuits can provide helpful forces making a person's back muscl...

What is the current status of trial NCT05802914?

This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2023-02-08. Estimated completion is 2025-04-26.

What conditions does trial NCT05802914 study?

This clinical trial studies the following conditions: Low Back Pain, Musculoskeletal Pain, Low Back Injury.

What interventions are being tested in trial NCT05802914?

The interventions under investigation include: Back Exosuit (DEVICE).

Who is sponsoring clinical trial NCT05802914?

This trial is sponsored by Wyss Institute at Harvard University, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05802914 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05802914's enrollment target sits among peer trials

97 62nd of 122 higher than 61 of 122 other Low Back Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03948490 · 97 participants · NA

    Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas

  • NCT04140487 · 97 participants · Phase 1

    Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm

  • NCT04196413 · 97 participants · Phase 1

    GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)

  • NCT05223816 · 97 participants · Phase 2

    An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05802914, the US trial registry maintained by the National Library of Medicine. NCT05802914 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.